Wealth Enhancement Advisory Services, LLC Rocket Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 18,230 shares of RCKT stock, worth $55,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,230
Previous 17,128
6.43%
Holding current value
$55,601
Previous $55,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
96.4MCall Options Held
563KPut Options Held
418K-
Rtw Investments, LP New York, NY17.7MShares$53.9 Million0.77% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.47MShares$25.8 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.89MShares$21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18.9 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA3.9MShares$11.9 Million2.3% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $231M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...